These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 30335633)
1. A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares. McCall WV; Pillai A; Case D; McCloud L; Nolla T; Branch F; Youssef NA; Moraczewski J; Tauhidul L; Pandya CD; Rosenquist PB J Clin Psychopharmacol; 2018 Dec; 38(6):618-621. PubMed ID: 30335633 [TBL] [Abstract][Full Text] [Related]
2. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans. Raskind MA; Peskind ER; Chow B; Harris C; Davis-Karim A; Holmes HA; Hart KL; McFall M; Mellman TA; Reist C; Romesser J; Rosenheck R; Shih MC; Stein MB; Swift R; Gleason T; Lu Y; Huang GD N Engl J Med; 2018 Feb; 378(6):507-517. PubMed ID: 29414272 [TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans. Germain A; Richardson R; Moul DE; Mammen O; Haas G; Forman SD; Rode N; Begley A; Nofzinger EA J Psychosom Res; 2012 Feb; 72(2):89-96. PubMed ID: 22281448 [TBL] [Abstract][Full Text] [Related]
4. Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder. Peskind ER; Bonner LT; Hoff DJ; Raskind MA J Geriatr Psychiatry Neurol; 2003 Sep; 16(3):165-71. PubMed ID: 12967060 [TBL] [Abstract][Full Text] [Related]
5. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. Raskind MA; Thompson C; Petrie EC; Dobie DJ; Rein RJ; Hoff DJ; McFall ME; Peskind ER J Clin Psychiatry; 2002 Jul; 63(7):565-8. PubMed ID: 12143911 [TBL] [Abstract][Full Text] [Related]
6. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Raskind MA; Peterson K; Williams T; Hoff DJ; Hart K; Holmes H; Homas D; Hill J; Daniels C; Calohan J; Millard SP; Rohde K; O'Connell J; Pritzl D; Feiszli K; Petrie EC; Gross C; Mayer CL; Freed MC; Engel C; Peskind ER Am J Psychiatry; 2013 Sep; 170(9):1003-10. PubMed ID: 23846759 [TBL] [Abstract][Full Text] [Related]
7. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. Taylor F; Raskind MA J Clin Psychopharmacol; 2002 Feb; 22(1):82-5. PubMed ID: 11799347 [TBL] [Abstract][Full Text] [Related]
8. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Taylor FB; Martin P; Thompson C; Williams J; Mellman TA; Gross C; Peskind ER; Raskind MA Biol Psychiatry; 2008 Mar; 63(6):629-32. PubMed ID: 17868655 [TBL] [Abstract][Full Text] [Related]
9. Prazosin for treatment of nightmares related to posttraumatic stress disorder. Taylor HR; Freeman MK; Cates ME Am J Health Syst Pharm; 2008 Apr; 65(8):716-22. PubMed ID: 18387899 [TBL] [Abstract][Full Text] [Related]
10. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Raskind MA; Peskind ER; Hoff DJ; Hart KL; Holmes HA; Warren D; Shofer J; O'Connell J; Taylor F; Gross C; Rohde K; McFall ME Biol Psychiatry; 2007 Apr; 61(8):928-34. PubMed ID: 17069768 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder. George KC; Kebejian L; Ruth LJ; Miller CW; Himelhoch S J Trauma Dissociation; 2016; 17(4):494-510. PubMed ID: 26835889 [TBL] [Abstract][Full Text] [Related]
12. Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart Review. Roepke S; Danker-Hopfe H; Repantis D; Behnia B; Bernard F; Hansen ML; Otte C Pharmacopsychiatry; 2017 Jan; 50(1):26-31. PubMed ID: 27276365 [No Abstract] [Full Text] [Related]
13. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Raskind MA; Peskind ER; Kanter ED; Petrie EC; Radant A; Thompson CE; Dobie DJ; Hoff D; Rein RJ; Straits-Tröster K; Thomas RG; McFall MM Am J Psychiatry; 2003 Feb; 160(2):371-3. PubMed ID: 12562588 [TBL] [Abstract][Full Text] [Related]
14. Prazosin in the treatment of PTSD. Green B J Psychiatr Pract; 2014 Jul; 20(4):253-9. PubMed ID: 25036580 [TBL] [Abstract][Full Text] [Related]
15. Prazosin in Children and Adolescents With Posttraumatic Stress Disorder Who Have Nightmares: A Systematic Review. Akinsanya A; Marwaha R; Tampi RR J Clin Psychopharmacol; 2017 Feb; 37(1):84-88. PubMed ID: 27930498 [TBL] [Abstract][Full Text] [Related]
16. Insomnia symptoms, nightmares, and suicidal ideation in a college student sample. Nadorff MR; Nazem S; Fiske A Sleep; 2011 Jan; 34(1):93-8. PubMed ID: 21203379 [TBL] [Abstract][Full Text] [Related]
17. Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder. Taylor FB; Lowe K; Thompson C; McFall MM; Peskind ER; Kanter ED; Allison N; Williams J; Martin P; Raskind MA Biol Psychiatry; 2006 Apr; 59(7):577-81. PubMed ID: 16460691 [TBL] [Abstract][Full Text] [Related]
18. Help Desk Answers: Is prazosin effective for PTSD-associated nightmares? Abul-Husn N; Kipp A; Looney E; Palmer T J Fam Pract; 2015 Dec; 64(12):804. PubMed ID: 26844999 [No Abstract] [Full Text] [Related]
19. Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials. Khachatryan D; Groll D; Booij L; Sepehry AA; Schütz CG Gen Hosp Psychiatry; 2016; 39():46-52. PubMed ID: 26644317 [TBL] [Abstract][Full Text] [Related]
20. Preliminary findings concerning the use of prazosin for the treatment of posttraumatic nightmares in a refugee population. Boynton L; Bentley J; Strachan E; Barbato A; Raskind M J Psychiatr Pract; 2009 Nov; 15(6):454-9. PubMed ID: 19934720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]